Statistical significance and clinical utility

Affiliations

¹ Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Maimonides Medical Center, 4802 10th Ave., Brooklyn, NY 11219. Electronic address: lauracgilroy@gmail.com.
² Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Thomas Jefferson University Hospital, Philadelphia, PA.

Comment

Laura C Gilroy et al. Am J Obstet Gynecol. 2022 Aug.

. 2022 Aug;227(2):372.

doi: 10.1016/j.ajog.2022.03.059. Epub 2022 Apr 2.

¹ Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Maimonides Medical Center, 4802 10th Ave., Brooklyn, NY 11219. Electronic address: lauracgilroy@gmail.com.
² Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Thomas Jefferson University Hospital, Philadelphia, PA.

No abstract available

Comment on

Changes in obstetrical practices and pregnancy outcomes following the ARRIVE trial.
Gilroy LC, Al-Kouatly HB, Minkoff HL, McLaren RA Jr. Gilroy LC, et al. Am J Obstet Gynecol. 2022 May;226(5):716.e1-716.e12. doi: 10.1016/j.ajog.2022.02.003. Epub 2022 Feb 6. Am J Obstet Gynecol. 2022. PMID: 35139334 Clinical Trial.
Elective induction in low-risk nulliparous women at 39 weeks' gestation: is it worse changing obstetrical practices?
Vouga M, Desseauve D. Vouga M, et al. Am J Obstet Gynecol. 2022 Aug;227(2):371. doi: 10.1016/j.ajog.2022.03.058. Epub 2022 Apr 2. Am J Obstet Gynecol. 2022. PMID: 35381193 No abstract available.